Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface

Haoran Tang(University of Manchester), Richard Marais(Macclesfield College)

Nature Communications

April 18, 2017

10.1038/ncomms14909

Cited by 87

Related Papers

Mutations of the BRAF gene in human cancer

|Nature|2002|10.7k

Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF

|Cell|2010|1.5k

A Mouse Model of Melanoma Driven by Oncogenic KRAS

|Cancer Research|2010|76

The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers

|Annals of Oncology|2020|21

Brain microenvironment-driven resistance to immune and targeted therapies in acral melanoma

|ESMO Open|2020|6